TherapeuticsMD, Inc. (BST:29TA)

Market Cap	18.97M +52.9%
Revenue (ttm)	2.86M +27.8%
Net Income	-189.94K
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	1.570
Previous Close	1.570
Day's Range	1.530 - 1.590
52-Week Range	1.120 - 2.400
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About TherapeuticsMD

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2008
• Employees: 1
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: 29TA

Financial Performance

In 2025, TherapeuticsMD's revenue was $3.02 million, an increase of 71.61% compared to the previous year's $1.76 million. Losses were -$569,000, -73.91% less than in 2024.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 30, 2026

Data Sources Report a data error